This department houses a team of competent scientists from diverse fields, including pharmacology, biochemistry, and other allied life sciences. Our divisions are well-equipped with sophisticated instruments tailored for in vitro pharmacological assays, supported by a central animal facility that is registered under the Committee for the Purpose of Control and Supervision of Experiments (CPCSEA).

The services provided are designed in accordance with WHO international guidelines and conducted in full compliance with NAFDAC regulations, ensuring that our clients meet the highest standards for safety and efficacy. These services cater to producers of phytopharmaceuticals, providing critical insights into the pharmacological and toxicological profiles of their products.

Through rigorous acute toxicity assessments, our experts evaluate the immediate effects of bioactive compounds, determining safe dosage ranges and identifying potential adverse reactions. These studies are essential in establishing preliminary safety data before advancing to more complex pharmacological investigations. Our in vitro pharmacology division employs cutting-edge cell-based assays to analyze the mechanisms of action, potency, and therapeutic potential of herbal formulations, ensuring a scientific foundation for efficacy claims.

In vivo pharmacology studies, conducted within our CPCSEA-registered animal facility, provide deeper insights into the systemic effects, bioavailability, and pharmacokinetics of test compounds. Complementing these, our clinical pharmacology division facilitates translational research, bridging preclinical findings with human applications. By offering a comprehensive suite of pharmacological and toxicological evaluations, Tradomed empowers phytopharmaceutical manufacturers with the critical data necessary for regulatory approval and market success.